肿瘤切除程度对脑胶质瘤光动力治疗后脑水肿及预后的影响

李婧萱, 闫秀伟, 胡韶山

PDF(1070 KB)
PDF(1070 KB)
重庆医科大学学报 ›› 2024, Vol. 49 ›› Issue (09) : 1163-1170. DOI: 10.13406/j.cnki.cyxb.003577
临床研究

肿瘤切除程度对脑胶质瘤光动力治疗后脑水肿及预后的影响

作者信息 +

Influence of the degree of tumor resection on cerebral edema and prognosis after photodynamic therapy for gliomas

Author information +
History +

摘要

目的 使用光动力疗法(photodynamic therapy,PDT)辅助显微手术的综合治疗可以有效改善恶性脑胶质瘤患者的预后,提高生存率。本研究将探讨肿瘤的不同切除程度对高级别胶质瘤PDT后脑水肿及预后的影响。 方法 对2020年1月至2022年12月浙江省人民医院进行PDT辅助显微手术的高级别胶质瘤患者进行回顾性病例对照研究,收集患者基线资料和生存数据,对比肿瘤的不同切除程度对高级别胶质瘤PDT后脑水肿及预后的影响。 结果 近全切除组纳入30例,次全切除组纳入26例进行分析。通过统计发现,接受光动力辅助近全切除的患者术后脑水肿程度更低(16.67%的近全切除组患者出现Ⅲ级脑水肿,50%的次全切除组患者出现Ⅲ级脑水肿,P=0.011),其无进展生存期(progression free survival,PFS)(近全切除组15.63个月vs. 次全切除组8.36个月,P=0.002 5)也明显优于接受光动力辅助次全切除的患者。近全切除组患者生存质量更高(近全切除组患者的生存质量评分明显大于次全切除组,术后3个月P<0.001,术后6个月P=0.002)。 结论 光动力疗法辅助近全切除的综合治疗方式可显著降低高级别胶质瘤患者术后脑水肿程度,有助于提高患者术后生存质量、抑制肿瘤的复发以及延长患者的总生存期。

Abstract

Objective To investigate the influence of different degrees of tumor resection on cerebral edema and prognosis after photodynamic therapy(PDT) for high-grade glioma,since multimodality therapy with PDT and microsurgery can effectively improve the prognosis and survival rate of patients with malignant glioma. Methods A retrospective case-control study was conducted for the patients with high-grade glioma who underwent PDT and microsurgery in Zhejiang Provincial People’s Hospital from January 2020 to December 2022,and baseline data and survival data were collected from all patients. The influence of different degrees of tumor resection on cerebral edema and prognosis after PDT for high-grade glioma was analyzed and compared. Results There were 30 cases in the near-total resection group and 26 cases in the subtotal resection group. The statistical analysis showed that the patients receiving photodynamic-assisted near-total resection had a lower degree of postoperative cerebral edema(16.67% of the patients in the near-total resection group developed grade Ⅲ cerebral edema,and 50% of the patients in the subtotal resection group developed grade Ⅲ cerebral edema,P=0.011),as well as significantly better progression-free survival than those receiving photodynamic-assisted subtotal resection(15.63 months vs. 8.36 months,P=0.0025). The patients in the near-total resection group had a better quality of life,and the near-total resection group had a significantly higher quality of life score than the subtotal resection group (three months after surgery: P<0.001;six months after surgery:P=0.002). Conclusion The multimodality therapy with PDT and near-total resection can significantly reduce the degree of cerebral edema in patients with high-grade glioma and help to improve postoperative quality of life,inhibit tumor recurrence,and prolong the overall survival of patients.

关键词

胶质瘤 / 光动力 / 近全切除 / 次全切除 / 脑水肿

Key words

glioma / photodynamic therapy / near-total resection / sub-total resection / cerebral edema

中图分类号

R61 / R64

引用本文

导出引用
李婧萱 , 闫秀伟 , 胡韶山. 肿瘤切除程度对脑胶质瘤光动力治疗后脑水肿及预后的影响. 重庆医科大学学报. 2024, 49(09): 1163-1170 https://doi.org/10.13406/j.cnki.cyxb.003577
Li Jingxuan, Yan Xiuwei, Hu Shaoshan. Influence of the degree of tumor resection on cerebral edema and prognosis after photodynamic therapy for gliomas[J]. Journal of Chongqing Medical University. 2024, 49(09): 1163-1170 https://doi.org/10.13406/j.cnki.cyxb.003577

参考文献

1
Arvold ND Lee EQ Mehta MP,et al. Updates in the management of brain metastases[J]. Neuro-oncology201618(8):1043-1065.
2
Ostrom QT Gittleman H Xu J,et al. CBTRUS statistical report:primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013[J]. Neuro Oncol201618(suppl_5):v1-v75.
3
Haque W Thong Y Verma V,et al. Patterns of management and outcomes of unifocal versus multifocal glioblastoma[J]. J Clin Neurosci202074:155-159.
4
Frosina G. Recapitulating the key advances in the diagnosis and prognosis of high-grade gliomas:second half of 2021 update[J]. Int J Mol Sci202324(7):6375.
5
Sun YZ Yan LF Han Y,et al. Differentiation of pseudoprogression from true progressionin glioblastoma patients after standard treatment:a machine learning strategy combinedwith radiomics features from T1-weighted contrast-enhanced imaging[J]. BMC Med Imaging202121(1):17.
6
Dong XZ Noorbakhsh A Hirshman BR,et al. Survival trends of grade I,II,and III astrocytoma patients and associated clinical practice patterns between 1999 and 2010:a SEER-based analysis[J]. Neurooncol Pract20163(1):29-38.
7
Smoll NR Hamilton B. Incidence and relative survival of anaplastic astrocytomas[J]. Neuro Oncol201416(10):1400-1407.
8
Ostrom QT Price M Neff C,et al. CBTRUS statistical report:primary brain and other central nervous system tumors diagnosed in the United States in 2015-2019[J]. Neuro Oncol202224(Suppl 5):v1-v95.
9
Ostrom QT Cioffi G Waite K,et al. CBTRUS statistical report:primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018[J]. Neuro Oncol202123(12 Suppl 2):iii1-iii105.
10
Valle RD Slof J Galván J,et al. Observational,retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study)[J]. Neurologia201429(3):131-138.
11
Li YP Rey-Dios R Roberts DW,et al. Intraoperative fluorescence-guided resection of high-grade gliomas:a comparison of the present techniques and evolution of future strategies[J]. World Neurosurg201482(1/2):175-185.
12
Bianconi A Bonada M Zeppa P,et al. How reliable is fluorescence-guided surgery in low-grade gliomas?A systematic review concerning different fluorophores[J]. Cancers202315(16):4130.
13
Mier-García JF Ospina-Santa S Orozco-Mera J,et al. Supramaximal versus gross total resection in Glioblastoma,IDH wild-type and Astrocytoma,IDH-mutant,grade 4,effect on overall and progression free survival:systematic review and meta-analysis[J]. J Neurooncol2023164(1):31-41.
14
Chanbour H Chotai S. Review of intraoperative adjuncts for maximal safe resection of gliomas and its impact on outcomes[J]. Cancers202214(22):5705.
15
Sanai N Berger MS. Surgical oncology for gliomas:the state of the art[J]. Nat Rev Clin Oncol201815(2):112-125.
16
Xu Y Abramov I Belykh E,et al. Characterization of ex vivo and in vivo intraoperative neurosurgical confocal laser endomicroscopy imaging[J]. Front Oncol202212:979748.
17
Cakmakci D Karakaslar EO Ruhland E,et al. Machine learning assisted intraoperative assessment of brain tumor margins using HRMAS NMR spectroscopy[J]. PLoS Comput Biol202016(11):e1008184.
18
Belykh E Shaffer KV Lin CQ,et al. Blood-brain barrier,blood-brain tumor barrier,and fluorescence-guided neurosurgical oncology:delivering optical labels to brain tumors[J]. Front Oncol202010:739.
19
Charalampaki P Nakamura M Athanasopoulos D,et al. Confocal-assisted multispectral fluorescent microscopy for brain tumor surgery[J]. Front Oncol20199:583.
20
Zhu MY Chang W Jing LK,et al. Dual-modality optical diagnosis for precise in vivo identification of tumors in neurosurgery[J]. Theranostics20199(10):2827-2842.
21
Hsia T Small JL Yekula A,et al. Systematic review of photodynamic therapy in gliomas[J]. Cancers202315(15):3918.
22
Leroy HA Guérin L Lecomte F,et al. Is interstitial photodynamic therapy for brain tumors ready for clinical practice?A systematic review[J]. Photodiagnosis Photodyn Ther202136:102492.
23
van Straten D Mashayekhi V de Bruijn HS,et al. Oncologic photodynamic therapy:basic principles,current clinical status and future directions[J]. Cancers20179(2):19.
24
Almenawer SA Badhiwala JH Alhazzani W,et al. Biopsy versus partial versus gross total resection in older patients with high-grade glioma:a systematic review and meta-analysis[J]. Neuro Oncol201517(6):868-881.
25
Steinhoff H Grumme T Kazner E,et al. Axial transverse computerized tomography in 73 glioblastomas[J]. Acta Neurochir197842(1/2):45-56.
26
Chambless LB Kistka HM Parker SL,et al. The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme[J]. J Neurooncol2015121(2):359-364.
27
Donohoe C Senge MO Arnaut LG,et al. Cell death in photodynamic therapy:from oxidative stress to anti-tumor immunity[J]. Biochim Biophys Acta Rev Cancer20191872(2):188308.
28
Turubanova VD Balalaeva IV Mishchenko TA,et al. Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine[J]. J Immunother Cancer20197(1):350.
29
Turubanova VD Mishchenko TA Balalaeva IV,et al. Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death[J]. Sci Rep202111(1):7205.
30
Travis ZD Sherchan P Hayes WK,et al. Surgically-induced brain injury:where are we now?[J]. Chin Neurosurg J20195:29.
31
Awad AW Karsy M Sanai N,et al. Impact of removed tumor volume and location on patient outcome in glioblastoma[J]. J Neurooncol2017135(1):161-171.
32
Agostinis P Berg K Cengel KA,et al. Photodynamic therapy of cancer:an update[J]. CA Cancer J Clin201161(4):250-281.
33
Overchuk M Weersink RA Wilson BC,et al. Photodynamic and photothermal therapies:synergy opportunities for nanomedicine[J]. ACS Nano202317(9):7979-8003.
34
Civantos FJ Karakullukcu B Biel M,et al. A review of photodynamic therapy for neoplasms of the head and neck[J]. Adv Ther201835(3):324-340.
35
Zhang XF Cong DM Shen DW,et al. The effect of bumetanide on photodynamic therapy-induced peri-tumor edema of C6 glioma xenografts[J]. Lasers Surg Med201446(5):422-430.
36
Li BO Meng C Zhang XF,et al. Effect of photodynamic therapy combined with torasemide on the expression of matrix metalloproteinase 2 and sodium-potassium-chloride cotransporter 1 in rat peritumoral edema and glioma[J]. Oncol Lett201611(3):2084-2090.
37
Seshadri M Bellnier DA. The vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid improves the antitumor efficacy and shortens treatment time associated with Photochlor-sensitized photodynamic therapy in vivo[J]. Photochem Photobiol200985(1):50-56.
38
Mathews MS Chighvinadze D Gach HM,et al. Cerebral edema following photodynamic therapy using endogenous and exogenous photosensitizers in normal brain[J]. Lasers Surg Med201143(9):892-900.
39
Lekic T Rolland W Manaenko A,et al. Evaluation of the hematoma consequences,neurobehavioral profiles,and histopathology in a rat model of pontine hemorrhage[J]. J Neurosurg2013118(2):465-477.
40
Sherchan P Huang L Wang YC,et al. Recombinant Slit2 attenuates neuroinflammation after surgical brain injury by inhibiting peripheral immune cell infiltration via Robo1-srGAP1 pathway in a rat model[J]. Neurobiol Dis201685:164-173.
41
Nase G Helm PJ,Enger,et al. Water entry into astrocytes during brain edema formation[J]. Glia200856(8):895-902.
42
Bartusik-Aebisher D Żołyniak A Barnaś E,et al. The use of photodynamic therapy in the treatment of brain tumors-a review of the literature[J]. Molecules202227(20):6847.
43
Zhang C Feng W Li YS,et al. Age differences in photodynamic therapy-mediated opening of the blood-brain barrier through the optical clearing skull window in mice[J]. Lasers Surg Med201951(7):625-633.
44
Li F Zhu G Lin J,et al. Photodynamic therapy increases brain edema and intracranial pressure in a rabbit brain tumor model[J]. Acta Neurochir Suppl200696:422-425.
45
Leroy HA Vermandel M Vignion-Dewalle AS,et al. Interstitial photodynamic therapy and glioblastoma:light fractionation in a preclinical model[J]. Lasers Surg Med201749(5):506-515.
46
Ren ZY Wen J Mo YY,et al. A systematic review and meta-analysis of fluorescent-guided resection and therapy-based photodynamics on the survival of patients with glioma[J]. Lasers Med Sci202237(2):789-797.

基金

2022年浙江省人民医院杰出领军人才资助项目(C-2022-YYJCLJRC01)

评论

PDF(1070 KB)

Accesses

Citation

Detail

段落导航
相关文章

/